Shell (NYSE:SHEL) +3.2% in Thursday's trading despite missing Q4 earnings and revenue estimates, weighed by weaker oil and ...

Passenger vehicle (PV) revenues also fell by 4.3 per cent, but EBITDA margins improved by 120 basis points to 7.8 per cent, driven by cost controls and the PLI incentive ...

Brookfield real estate investment trust (REIT) reported an annual increase of 11 per cent in its net operating income (NOI) ...

Q4 2024 Management View CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, ...

Revenue increased by 9.36% YoY & profit increased by 78.17% YoY, profit at ₹31.09 crore and revenue at ₹1269.52 crore.

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

American Financial Group is a mid-sized P&C insurer with strong underwriting performance and a focus on specialty lines. Read ...

In this article, we will take a look at the 12 stocks that will double in 2025.

L&T stock price has remained weak in the past one year. While L&T shares are down 3% in one month, they have fallen 8% in six months and over 4% in one year.

L&T reports 14% profit increase, Rs 1 lakh crore order inflows, strong infrastructure and energy sectors drive growth.

Phoenix Malls, Ajanta Pharma, Prestige Estates Projects, Shree Cement, Welspun Living, Vedant Fashions, Astral and Dr Lal's PathLabs will also announce results for quarter ended December.

Shares of Biocon Ltd closed slightly higher at ₹357.15 on the BSE today, up 0.44% or ₹1.55, ahead of the earnings announcement.